Illumina Body Map 2 (GSE30611)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
EBF1
|
ENSG00000164330.17 | EBF transcription factor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
EBF1 | hg38_v1_chr5_-_159099909_159099925 | -0.29 | 1.1e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr22_+_22887780 | 10.97 |
ENST00000532223.2
ENST00000526893.6 ENST00000531372.1 |
IGLL5
|
immunoglobulin lambda like polypeptide 5 |
chr14_-_106301848 | 5.31 |
ENST00000390611.2
|
IGHV2-26
|
immunoglobulin heavy variable 2-26 |
chr10_+_79610932 | 4.87 |
ENST00000428376.6
ENST00000398636.8 ENST00000419470.6 ENST00000429958.5 |
SFTPA1
|
surfactant protein A1 |
chr6_-_31582415 | 4.59 |
ENST00000429299.3
ENST00000446745.2 |
LTB
|
lymphotoxin beta |
chr22_+_22880706 | 4.42 |
ENST00000390319.2
|
IGLV3-1
|
immunoglobulin lambda variable 3-1 |
chr12_-_48865863 | 4.20 |
ENST00000309739.6
|
RND1
|
Rho family GTPase 1 |
chr5_-_139389905 | 3.99 |
ENST00000302125.9
|
MZB1
|
marginal zone B and B1 cell specific protein |
chr22_+_22697789 | 3.85 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
chr22_-_37244237 | 3.85 |
ENST00000401529.3
ENST00000249071.11 |
RAC2
|
Rac family small GTPase 2 |
chr22_+_22195753 | 3.79 |
ENST00000390285.4
|
IGLV6-57
|
immunoglobulin lambda variable 6-57 |
chr14_-_105845677 | 3.67 |
ENST00000390556.6
|
IGHD
|
immunoglobulin heavy constant delta |
chr10_-_79560386 | 3.67 |
ENST00000372327.9
ENST00000417041.1 ENST00000640627.1 ENST00000372325.7 |
SFTPA2
|
surfactant protein A2 |
chr14_-_105588322 | 3.47 |
ENST00000497872.4
ENST00000390539.2 |
IGHA2
|
immunoglobulin heavy constant alpha 2 (A2m marker) |
chr1_-_161631152 | 3.39 |
ENST00000421702.3
ENST00000650385.1 |
FCGR3B
|
Fc fragment of IgG receptor IIIb |
chr16_+_56638659 | 3.37 |
ENST00000290705.12
|
MT1A
|
metallothionein 1A |
chr2_-_89320146 | 3.19 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 |
chr22_-_37244417 | 3.18 |
ENST00000405484.5
ENST00000441619.5 ENST00000406508.5 |
RAC2
|
Rac family small GTPase 2 |
chr22_+_22758698 | 3.09 |
ENST00000390312.2
|
IGLV2-14
|
immunoglobulin lambda variable 2-14 |
chr19_+_49119531 | 3.07 |
ENST00000334186.9
|
PPFIA3
|
PTPRF interacting protein alpha 3 |
chr1_-_161631032 | 3.07 |
ENST00000534776.1
ENST00000613418.4 ENST00000614870.4 |
FCGR3B
|
Fc fragment of IgG receptor IIIb |
chr22_+_22818994 | 3.06 |
ENST00000390316.2
|
IGLV3-9
|
immunoglobulin lambda variable 3-9 |
chr22_+_22322452 | 2.96 |
ENST00000390290.3
|
IGLV1-51
|
immunoglobulin lambda variable 1-51 |
chr11_+_60455839 | 2.94 |
ENST00000532491.5
ENST00000532073.5 ENST00000345732.9 ENST00000534668.6 ENST00000528313.1 ENST00000533306.6 ENST00000674194.1 |
MS4A1
|
membrane spanning 4-domains A1 |
chr2_+_89851723 | 2.90 |
ENST00000429992.2
|
IGKV2D-40
|
immunoglobulin kappa variable 2D-40 |
chr1_-_156248084 | 2.84 |
ENST00000652405.1
ENST00000335852.6 ENST00000540423.5 ENST00000612424.4 ENST00000613336.4 ENST00000623241.3 |
PAQR6
|
progestin and adipoQ receptor family member 6 |
chr2_-_89177160 | 2.84 |
ENST00000484817.1
|
IGKV2-24
|
immunoglobulin kappa variable 2-24 |
chr1_-_161549793 | 2.75 |
ENST00000443193.6
|
FCGR3A
|
Fc fragment of IgG receptor IIIa |
chr22_+_22734577 | 2.70 |
ENST00000390310.3
|
IGLV2-18
|
immunoglobulin lambda variable 2-18 |
chr22_+_22792485 | 2.69 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
chr22_+_22098683 | 2.68 |
ENST00000390283.2
|
IGLV8-61
|
immunoglobulin lambda variable 8-61 |
chr2_-_157444044 | 2.61 |
ENST00000264192.8
|
CYTIP
|
cytohesin 1 interacting protein |
chr1_-_161549892 | 2.60 |
ENST00000426740.7
|
FCGR3A
|
Fc fragment of IgG receptor IIIa |
chr2_+_89862438 | 2.60 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
chr16_-_85112390 | 2.53 |
ENST00000629253.1
ENST00000539556.6 |
CIBAR2
|
CBY1 interacting BAR domain containing 2 |
chr14_-_106579223 | 2.51 |
ENST00000390626.2
|
IGHV5-51
|
immunoglobulin heavy variable 5-51 |
chr22_+_22895368 | 2.49 |
ENST00000390321.2
|
IGLC1
|
immunoglobulin lambda constant 1 |
chr14_-_105708627 | 2.48 |
ENST00000641837.1
ENST00000390547.3 |
IGHA1
|
immunoglobulin heavy constant alpha 1 |
chr22_+_22030934 | 2.46 |
ENST00000390282.2
|
IGLV4-69
|
immunoglobulin lambda variable 4-69 |
chr19_-_50365625 | 2.45 |
ENST00000598915.5
ENST00000253719.7 |
NAPSA
|
napsin A aspartic peptidase |
chr2_+_89947508 | 2.42 |
ENST00000491977.1
|
IGKV2D-29
|
immunoglobulin kappa variable 2D-29 |
chr14_-_105940235 | 2.38 |
ENST00000390593.2
|
IGHV6-1
|
immunoglobulin heavy variable 6-1 |
chr22_+_22922594 | 2.37 |
ENST00000390331.3
|
IGLC7
|
immunoglobulin lambda constant 7 |
chr19_+_41877267 | 2.30 |
ENST00000221972.8
ENST00000597454.1 ENST00000444740.2 |
CD79A
|
CD79a molecule |
chr8_+_22161788 | 2.29 |
ENST00000521315.5
ENST00000437090.6 ENST00000679463.1 ENST00000520605.5 ENST00000522109.5 ENST00000524255.5 ENST00000523296.1 |
SFTPC
|
surfactant protein C |
chr11_+_61752603 | 2.27 |
ENST00000278836.10
|
MYRF
|
myelin regulatory factor |
chr2_+_90004792 | 2.23 |
ENST00000462693.1
|
IGKV2D-24
|
immunoglobulin kappa variable 2D-24 (non-functional) |
chr1_+_6026325 | 2.22 |
ENST00000666299.1
ENST00000652845.1 |
KCNAB2
|
potassium voltage-gated channel subfamily A regulatory beta subunit 2 |
chr22_+_22811737 | 2.18 |
ENST00000390315.3
|
IGLV3-10
|
immunoglobulin lambda variable 3-10 |
chr1_-_156248038 | 2.17 |
ENST00000470198.5
ENST00000292291.10 ENST00000356983.7 |
PAQR6
|
progestin and adipoQ receptor family member 6 |
chr1_-_225877630 | 2.16 |
ENST00000436966.1
|
TMEM63A
|
transmembrane protein 63A |
chr19_+_41755520 | 2.13 |
ENST00000199764.7
|
CEACAM6
|
CEA cell adhesion molecule 6 |
chr16_+_85914267 | 2.13 |
ENST00000569607.1
|
IRF8
|
interferon regulatory factor 8 |
chr2_+_218382265 | 2.11 |
ENST00000233202.11
|
SLC11A1
|
solute carrier family 11 member 1 |
chr14_-_106803221 | 2.10 |
ENST00000390636.2
|
IGHV3-73
|
immunoglobulin heavy variable 3-73 |
chr22_+_22822658 | 2.09 |
ENST00000620395.2
|
IGLV2-8
|
immunoglobulin lambda variable 2-8 |
chr22_+_22343185 | 2.07 |
ENST00000427632.2
|
IGLV9-49
|
immunoglobulin lambda variable 9-49 |
chr17_-_81128873 | 2.06 |
ENST00000572339.5
|
AATK
|
apoptosis associated tyrosine kinase |
chr2_-_89143133 | 2.05 |
ENST00000492167.1
|
IGKV3-20
|
immunoglobulin kappa variable 3-20 |
chr2_+_181457342 | 2.03 |
ENST00000397033.7
ENST00000233573.6 |
ITGA4
|
integrin subunit alpha 4 |
chr6_-_32184287 | 1.99 |
ENST00000375069.7
ENST00000375070.7 ENST00000438221.6 ENST00000620802.4 ENST00000538695.2 |
AGER
|
advanced glycosylation end-product specific receptor |
chr7_-_100468063 | 1.99 |
ENST00000423266.5
ENST00000456330.1 |
TSC22D4
|
TSC22 domain family member 4 |
chr19_-_38617928 | 1.99 |
ENST00000396857.7
ENST00000586296.5 |
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1 |
chr1_-_36482904 | 1.97 |
ENST00000373106.6
|
CSF3R
|
colony stimulating factor 3 receptor |
chr2_-_89027700 | 1.97 |
ENST00000483158.1
|
IGKV3-11
|
immunoglobulin kappa variable 3-11 |
chr19_+_49335396 | 1.97 |
ENST00000598095.5
ENST00000426897.6 ENST00000323906.9 ENST00000535669.6 ENST00000597602.1 ENST00000595660.1 |
CD37
|
CD37 molecule |
chr14_-_106335613 | 1.95 |
ENST00000603660.1
|
IGHV3-30
|
immunoglobulin heavy variable 3-30 |
chr8_+_141128581 | 1.94 |
ENST00000519811.6
|
DENND3
|
DENN domain containing 3 |
chr1_+_6026013 | 1.94 |
ENST00000428161.6
ENST00000352527.6 ENST00000663169.1 ENST00000656198.1 ENST00000602612.5 |
KCNAB2
|
potassium voltage-gated channel subfamily A regulatory beta subunit 2 |
chr2_-_89245596 | 1.93 |
ENST00000468494.1
|
IGKV2-30
|
immunoglobulin kappa variable 2-30 |
chr1_-_156248013 | 1.93 |
ENST00000368270.2
|
PAQR6
|
progestin and adipoQ receptor family member 6 |
chr17_-_36090133 | 1.91 |
ENST00000613922.2
|
CCL3
|
C-C motif chemokine ligand 3 |
chr2_-_86861871 | 1.89 |
ENST00000390655.12
ENST00000393759.6 ENST00000349455.7 ENST00000331469.6 ENST00000393761.6 ENST00000431506.3 |
CD8B
|
CD8b molecule |
chr17_+_7336557 | 1.89 |
ENST00000570457.6
|
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
chr2_+_89959979 | 1.89 |
ENST00000453166.2
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
chr14_-_106154113 | 1.89 |
ENST00000390603.2
|
IGHV3-15
|
immunoglobulin heavy variable 3-15 |
chr19_-_15464525 | 1.88 |
ENST00000343625.12
|
RASAL3
|
RAS protein activator like 3 |
chr6_+_31723344 | 1.88 |
ENST00000480039.5
ENST00000375810.8 ENST00000375805.6 ENST00000375809.7 ENST00000649779.1 ENST00000375804.6 ENST00000375814.7 |
MPIG6B
|
megakaryocyte and platelet inhibitory receptor G6b |
chr6_-_32184243 | 1.88 |
ENST00000375055.6
ENST00000375076.9 |
AGER
|
advanced glycosylation end-product specific receptor |
chr15_-_22185402 | 1.85 |
ENST00000557788.2
|
IGHV4OR15-8
|
immunoglobulin heavy variable 4/OR15-8 (non-functional) |
chr14_-_106737547 | 1.85 |
ENST00000632209.1
|
IGHV1-69-2
|
immunoglobulin heavy variable 1-69-2 |
chr9_+_124291935 | 1.84 |
ENST00000546191.5
|
NEK6
|
NIMA related kinase 6 |
chr22_+_22588155 | 1.84 |
ENST00000390302.3
|
IGLV2-33
|
immunoglobulin lambda variable 2-33 (non-functional) |
chr1_-_27374816 | 1.82 |
ENST00000270879.9
ENST00000354982.2 |
FCN3
|
ficolin 3 |
chr2_-_89222461 | 1.82 |
ENST00000482769.1
|
IGKV2-28
|
immunoglobulin kappa variable 2-28 |
chr19_-_11577434 | 1.82 |
ENST00000590832.1
|
ACP5
|
acid phosphatase 5, tartrate resistant |
chr9_-_114348966 | 1.80 |
ENST00000374079.8
|
AKNA
|
AT-hook transcription factor |
chr15_-_21742799 | 1.80 |
ENST00000622410.2
|
ENSG00000278263.2
|
novel protein, identical to IGHV4-4 |
chr14_-_106108453 | 1.77 |
ENST00000632950.2
|
IGHV5-10-1
|
immunoglobulin heavy variable 5-10-1 |
chr1_-_84997079 | 1.72 |
ENST00000284027.5
ENST00000370608.8 |
MCOLN2
|
mucolipin TRP cation channel 2 |
chr2_+_95025700 | 1.70 |
ENST00000309988.9
ENST00000353004.7 ENST00000354078.7 ENST00000349807.3 |
MAL
|
mal, T cell differentiation protein |
chr11_-_47378391 | 1.69 |
ENST00000227163.8
|
SPI1
|
Spi-1 proto-oncogene |
chr19_-_38617912 | 1.68 |
ENST00000591517.5
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1 |
chr7_+_142618821 | 1.67 |
ENST00000390393.3
|
TRBV19
|
T cell receptor beta variable 19 |
chr6_-_30684744 | 1.67 |
ENST00000615892.4
|
PPP1R18
|
protein phosphatase 1 regulatory subunit 18 |
chr22_+_22162155 | 1.66 |
ENST00000390284.2
|
IGLV4-60
|
immunoglobulin lambda variable 4-60 |
chrX_+_130171903 | 1.61 |
ENST00000257017.5
|
RAB33A
|
RAB33A, member RAS oncogene family |
chr7_+_24284181 | 1.61 |
ENST00000407573.5
ENST00000242152.7 |
NPY
|
neuropeptide Y |
chr14_-_106627685 | 1.60 |
ENST00000390629.3
|
IGHV4-59
|
immunoglobulin heavy variable 4-59 |
chr22_+_22720615 | 1.59 |
ENST00000390309.2
|
IGLV3-19
|
immunoglobulin lambda variable 3-19 |
chr19_-_51646800 | 1.57 |
ENST00000599649.5
ENST00000429354.3 ENST00000360844.6 |
SIGLEC5
SIGLEC14
|
sialic acid binding Ig like lectin 5 sialic acid binding Ig like lectin 14 |
chr10_-_70602687 | 1.57 |
ENST00000638674.1
|
PRF1
|
perforin 1 |
chr2_-_88979016 | 1.55 |
ENST00000390247.2
|
IGKV3-7
|
immunoglobulin kappa variable 3-7 (non-functional) |
chr15_-_22160868 | 1.55 |
ENST00000604066.1
|
IGHV1OR15-1
|
immunoglobulin heavy variable 1/OR15-1 (non-functional) |
chr7_+_74209947 | 1.55 |
ENST00000475494.5
ENST00000398475.5 |
LAT2
|
linker for activation of T cells family member 2 |
chr14_-_106639589 | 1.53 |
ENST00000390630.3
|
IGHV4-61
|
immunoglobulin heavy variable 4-61 |
chr4_-_89836213 | 1.53 |
ENST00000618500.4
ENST00000508895.5 |
SNCA
|
synuclein alpha |
chr5_+_176810552 | 1.51 |
ENST00000329542.9
|
UNC5A
|
unc-5 netrin receptor A |
chr17_+_7336502 | 1.50 |
ENST00000158762.8
|
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
chr2_+_89985922 | 1.50 |
ENST00000390268.2
|
IGKV2D-26
|
immunoglobulin kappa variable 2D-26 |
chr17_-_78128731 | 1.50 |
ENST00000592063.5
ENST00000590602.6 ENST00000589271.5 |
TMC6
|
transmembrane channel like 6 |
chr16_-_56668034 | 1.48 |
ENST00000569500.5
ENST00000379811.4 ENST00000444837.6 |
MT1G
|
metallothionein 1G |
chrX_+_129779930 | 1.47 |
ENST00000356892.4
|
SASH3
|
SAM and SH3 domain containing 3 |
chr7_+_26291850 | 1.46 |
ENST00000338523.9
ENST00000446848.6 |
SNX10
|
sorting nexin 10 |
chr2_+_97713568 | 1.46 |
ENST00000264972.10
|
ZAP70
|
zeta chain of T cell receptor associated protein kinase 70 |
chr1_-_160523204 | 1.44 |
ENST00000368055.1
ENST00000368057.8 ENST00000368059.7 |
SLAMF6
|
SLAM family member 6 |
chr20_+_24949256 | 1.43 |
ENST00000480798.2
|
CST7
|
cystatin F |
chr11_-_47378494 | 1.43 |
ENST00000533030.1
|
SPI1
|
Spi-1 proto-oncogene |
chr7_+_50308672 | 1.43 |
ENST00000439701.2
ENST00000438033.5 ENST00000492782.6 |
IKZF1
|
IKAROS family zinc finger 1 |
chr11_-_111449981 | 1.42 |
ENST00000531398.1
|
POU2AF1
|
POU class 2 homeobox associating factor 1 |
chr8_+_23528947 | 1.42 |
ENST00000519973.6
|
SLC25A37
|
solute carrier family 25 member 37 |
chr8_+_141128612 | 1.41 |
ENST00000518347.5
ENST00000262585.6 ENST00000520986.5 ENST00000523058.5 ENST00000518668.5 |
DENND3
|
DENN domain containing 3 |
chr17_+_7336587 | 1.40 |
ENST00000575425.1
|
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
chr19_+_10289939 | 1.40 |
ENST00000221980.5
|
ICAM5
|
intercellular adhesion molecule 5 |
chr21_-_44910630 | 1.39 |
ENST00000320216.10
ENST00000397852.5 |
ITGB2
|
integrin subunit beta 2 |
chr7_+_74209989 | 1.39 |
ENST00000361082.7
ENST00000275635.11 ENST00000460943.6 ENST00000470709.1 |
LAT2
|
linker for activation of T cells family member 2 |
chr14_-_106875069 | 1.39 |
ENST00000390639.2
|
IGHV7-81
|
immunoglobulin heavy variable 7-81 (non-functional) |
chr1_-_27626496 | 1.38 |
ENST00000374003.7
|
FGR
|
FGR proto-oncogene, Src family tyrosine kinase |
chr6_-_30932147 | 1.38 |
ENST00000359086.4
|
SFTA2
|
surfactant associated 2 |
chr19_+_17527250 | 1.38 |
ENST00000599164.6
ENST00000449408.6 ENST00000600871.5 ENST00000599124.1 |
NIBAN3
|
niban apoptosis regulator 3 |
chr2_+_113406368 | 1.38 |
ENST00000453673.3
|
IGKV1OR2-108
|
immunoglobulin kappa variable 1/OR2-108 (non-functional) |
chr14_-_54902807 | 1.36 |
ENST00000543643.6
ENST00000536224.2 ENST00000395514.5 ENST00000491895.7 |
GCH1
|
GTP cyclohydrolase 1 |
chr22_+_22899481 | 1.35 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
chr11_+_67404077 | 1.35 |
ENST00000542590.2
ENST00000312390.9 |
TBC1D10C
|
TBC1 domain family member 10C |
chr6_-_24877262 | 1.34 |
ENST00000378023.8
ENST00000540914.5 |
RIPOR2
|
RHO family interacting cell polarization regulator 2 |
chr17_-_50129792 | 1.34 |
ENST00000503131.1
|
SAMD14
|
sterile alpha motif domain containing 14 |
chr19_-_49442360 | 1.33 |
ENST00000600601.5
|
SLC17A7
|
solute carrier family 17 member 7 |
chr3_+_197286 | 1.33 |
ENST00000421198.5
|
CHL1
|
cell adhesion molecule L1 like |
chr20_-_23421409 | 1.32 |
ENST00000377026.4
ENST00000398425.7 ENST00000432543.6 ENST00000617876.4 |
NAPB
|
NSF attachment protein beta |
chr1_-_44031446 | 1.31 |
ENST00000372310.8
ENST00000466926.1 |
SLC6A9
|
solute carrier family 6 member 9 |
chr16_+_67645166 | 1.31 |
ENST00000545661.5
|
CARMIL2
|
capping protein regulator and myosin 1 linker 2 |
chr3_-_10505508 | 1.31 |
ENST00000643662.1
ENST00000397077.6 ENST00000360273.7 |
ATP2B2
|
ATPase plasma membrane Ca2+ transporting 2 |
chr2_-_241858882 | 1.30 |
ENST00000334409.10
|
PDCD1
|
programmed cell death 1 |
chr17_-_78128630 | 1.30 |
ENST00000306591.11
|
TMC6
|
transmembrane channel like 6 |
chr20_+_46029165 | 1.30 |
ENST00000616201.4
ENST00000616202.4 ENST00000616933.4 ENST00000626937.2 |
SLC12A5
|
solute carrier family 12 member 5 |
chr15_-_21718245 | 1.30 |
ENST00000630556.1
|
ENSG00000281179.1
|
novel gene identicle to IGHV1OR15-1 |
chr1_-_44031352 | 1.28 |
ENST00000372306.7
ENST00000475075.6 |
SLC6A9
|
solute carrier family 6 member 9 |
chr22_+_22395005 | 1.28 |
ENST00000390298.2
|
IGLV7-43
|
immunoglobulin lambda variable 7-43 |
chr12_+_52006935 | 1.28 |
ENST00000293662.9
|
TAMALIN
|
trafficking regulator and scaffold protein tamalin |
chr12_+_6868154 | 1.28 |
ENST00000462761.5
|
TPI1
|
triosephosphate isomerase 1 |
chr4_-_89837076 | 1.28 |
ENST00000506691.1
|
SNCA
|
synuclein alpha |
chr1_-_153390976 | 1.27 |
ENST00000368732.5
ENST00000368733.4 |
S100A8
|
S100 calcium binding protein A8 |
chr6_-_32763522 | 1.27 |
ENST00000435145.6
ENST00000437316.7 |
HLA-DQB2
|
major histocompatibility complex, class II, DQ beta 2 |
chr19_-_7702139 | 1.26 |
ENST00000346664.9
|
FCER2
|
Fc fragment of IgE receptor II |
chr3_-_183428085 | 1.26 |
ENST00000447025.6
ENST00000414362.6 |
MCF2L2
|
MCF.2 cell line derived transforming sequence-like 2 |
chr11_+_116829898 | 1.25 |
ENST00000227667.8
ENST00000375345.3 |
APOC3
|
apolipoprotein C3 |
chr11_-_441964 | 1.25 |
ENST00000332826.7
|
ANO9
|
anoctamin 9 |
chr1_+_6045914 | 1.25 |
ENST00000378083.7
|
KCNAB2
|
potassium voltage-gated channel subfamily A regulatory beta subunit 2 |
chr7_+_33905519 | 1.24 |
ENST00000650544.1
ENST00000648392.1 ENST00000649409.2 ENST00000648848.1 |
BMPER
|
BMP binding endothelial regulator |
chr19_-_7702124 | 1.23 |
ENST00000597921.6
|
FCER2
|
Fc fragment of IgE receptor II |
chr6_-_32184227 | 1.23 |
ENST00000450110.5
ENST00000375067.7 ENST00000375056.6 |
AGER
|
advanced glycosylation end-product specific receptor |
chr6_+_29827817 | 1.23 |
ENST00000360323.11
ENST00000376818.7 ENST00000376815.3 |
HLA-G
|
major histocompatibility complex, class I, G |
chr3_-_183427977 | 1.23 |
ENST00000473233.5
|
MCF2L2
|
MCF.2 cell line derived transforming sequence-like 2 |
chr7_+_26291898 | 1.22 |
ENST00000416246.5
|
SNX10
|
sorting nexin 10 |
chr17_-_44911281 | 1.22 |
ENST00000638304.1
ENST00000591880.2 ENST00000586125.2 ENST00000639921.1 |
GFAP
|
glial fibrillary acidic protein |
chr7_+_142300924 | 1.21 |
ENST00000455382.2
|
TRBV2
|
T cell receptor beta variable 2 |
chr16_+_56657999 | 1.21 |
ENST00000568475.1
|
MT1F
|
metallothionein 1F |
chr4_-_25863537 | 1.21 |
ENST00000502949.5
ENST00000264868.9 ENST00000513691.1 ENST00000514872.1 |
SEL1L3
|
SEL1L family member 3 |
chr10_-_70602759 | 1.20 |
ENST00000373209.2
|
PRF1
|
perforin 1 |
chr4_-_89836963 | 1.20 |
ENST00000420646.6
ENST00000673718.1 |
SNCA
|
synuclein alpha |
chr1_-_94925759 | 1.20 |
ENST00000415017.1
ENST00000545882.5 |
CNN3
|
calponin 3 |
chr19_+_7763210 | 1.20 |
ENST00000359059.10
ENST00000596363.5 ENST00000394122.7 ENST00000327325.10 |
CLEC4M
|
C-type lectin domain family 4 member M |
chr17_-_63932261 | 1.20 |
ENST00000349817.2
ENST00000006750.8 ENST00000392795.7 |
CD79B
|
CD79b molecule |
chr11_-_3840829 | 1.19 |
ENST00000396978.1
|
RHOG
|
ras homolog family member G |
chr19_-_10339610 | 1.19 |
ENST00000589261.5
ENST00000160262.10 ENST00000590569.1 ENST00000589580.1 ENST00000589249.1 |
ICAM3
|
intercellular adhesion molecule 3 |
chr7_+_142320677 | 1.19 |
ENST00000390381.3
|
TRBV5-1
|
T cell receptor beta variable 5-1 |
chr22_+_36863091 | 1.19 |
ENST00000650698.1
|
NCF4
|
neutrophil cytosolic factor 4 |
chr6_-_32763466 | 1.19 |
ENST00000427449.1
ENST00000411527.5 |
HLA-DQB2
|
major histocompatibility complex, class II, DQ beta 2 |
chr11_+_67403887 | 1.19 |
ENST00000526387.5
|
TBC1D10C
|
TBC1 domain family member 10C |
chr19_+_5914202 | 1.18 |
ENST00000588776.8
ENST00000588865.2 |
CAPS
|
calcyphosine |
chrX_-_155264471 | 1.18 |
ENST00000369454.4
|
RAB39B
|
RAB39B, member RAS oncogene family |
chr16_+_72063226 | 1.18 |
ENST00000540303.7
ENST00000356967.6 ENST00000561690.1 |
HPR
|
haptoglobin-related protein |
chr19_+_45692637 | 1.18 |
ENST00000012049.10
ENST00000366382.8 |
QPCTL
|
glutaminyl-peptide cyclotransferase like |
chr4_-_154612635 | 1.18 |
ENST00000407946.5
ENST00000405164.5 ENST00000336098.8 ENST00000393846.6 ENST00000404648.7 ENST00000443553.5 |
FGG
|
fibrinogen gamma chain |
chr17_-_78128778 | 1.18 |
ENST00000589553.5
|
TMC6
|
transmembrane channel like 6 |
chr7_+_142349135 | 1.17 |
ENST00000634383.1
|
TRBV6-2
|
T cell receptor beta variable 6-2 |
chr5_+_176810498 | 1.17 |
ENST00000509580.2
|
UNC5A
|
unc-5 netrin receptor A |
chr17_-_75844334 | 1.16 |
ENST00000592386.5
ENST00000412096.6 ENST00000586147.1 ENST00000207549.9 |
UNC13D
|
unc-13 homolog D |
chr6_-_32224060 | 1.15 |
ENST00000375023.3
|
NOTCH4
|
notch receptor 4 |
chr7_+_142352802 | 1.15 |
ENST00000634605.1
|
TRBV7-2
|
T cell receptor beta variable 7-2 |
chr9_-_35618367 | 1.15 |
ENST00000378431.5
ENST00000378430.3 ENST00000259633.9 |
CD72
|
CD72 molecule |
chr6_-_89315291 | 1.15 |
ENST00000402938.4
|
GABRR2
|
gamma-aminobutyric acid type A receptor subunit rho2 |
chr17_+_78130759 | 1.15 |
ENST00000590426.1
ENST00000318430.10 ENST00000590799.5 ENST00000589691.1 |
TMC8
|
transmembrane channel like 8 |
chr11_-_47378479 | 1.15 |
ENST00000533968.1
|
SPI1
|
Spi-1 proto-oncogene |
chr17_+_74737238 | 1.15 |
ENST00000392613.10
ENST00000613645.1 |
RAB37
|
RAB37, member RAS oncogene family |
chr17_-_38563986 | 1.14 |
ENST00000622519.4
|
SRCIN1
|
SRC kinase signaling inhibitor 1 |
chr22_+_22427517 | 1.14 |
ENST00000390300.2
|
IGLV5-37
|
immunoglobulin lambda variable 5-37 |
chr1_-_206923183 | 1.14 |
ENST00000525793.5
|
FCMR
|
Fc fragment of IgM receptor |
chr6_-_32666648 | 1.14 |
ENST00000399082.7
ENST00000399079.7 ENST00000374943.8 ENST00000434651.6 |
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1 |
chr10_-_15088768 | 1.14 |
ENST00000356189.6
|
ACBD7
|
acyl-CoA binding domain containing 7 |
chr5_-_177509814 | 1.13 |
ENST00000510898.7
ENST00000502885.5 ENST00000506493.5 |
DOK3
|
docking protein 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.1 | GO:1904596 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
0.9 | 2.6 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.8 | 4.0 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.8 | 2.4 | GO:0002432 | granuloma formation(GO:0002432) |
0.8 | 2.4 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
0.7 | 5.2 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.7 | 13.1 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.7 | 2.9 | GO:0040040 | thermosensory behavior(GO:0040040) |
0.7 | 2.1 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.7 | 3.5 | GO:0002357 | defense response to tumor cell(GO:0002357) |
0.7 | 2.8 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.7 | 3.4 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.7 | 4.0 | GO:0051621 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
0.7 | 6.7 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.7 | 2.6 | GO:2000910 | negative regulation of cholesterol import(GO:0060621) negative regulation of sterol import(GO:2000910) |
0.6 | 2.5 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.6 | 3.5 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.6 | 1.7 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.6 | 93.9 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.5 | 2.1 | GO:0070839 | L-arginine import(GO:0043091) divalent metal ion export(GO:0070839) arginine import(GO:0090467) |
0.5 | 1.6 | GO:1904692 | positive regulation of type B pancreatic cell proliferation(GO:1904692) |
0.5 | 1.0 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
0.5 | 1.4 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
0.5 | 1.4 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
0.4 | 1.3 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
0.4 | 1.7 | GO:0033037 | polysaccharide localization(GO:0033037) |
0.4 | 4.9 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.4 | 2.0 | GO:0032796 | uropod organization(GO:0032796) |
0.4 | 1.6 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.4 | 0.8 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
0.4 | 1.9 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.4 | 0.4 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.3 | 1.7 | GO:1903613 | regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
0.3 | 1.0 | GO:0046333 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
0.3 | 1.0 | GO:1900155 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
0.3 | 1.0 | GO:0030221 | basophil differentiation(GO:0030221) |
0.3 | 1.3 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.3 | 0.3 | GO:0003133 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) |
0.3 | 1.0 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.3 | 1.9 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.3 | 1.2 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.3 | 1.2 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.3 | 2.5 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.3 | 0.6 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.3 | 5.0 | GO:0008228 | opsonization(GO:0008228) |
0.3 | 0.9 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
0.3 | 0.9 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
0.3 | 2.7 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.3 | 0.6 | GO:0034226 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
0.3 | 0.9 | GO:0019085 | early viral transcription(GO:0019085) |
0.3 | 2.7 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.3 | 2.4 | GO:0045007 | depurination(GO:0045007) |
0.3 | 1.1 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.3 | 0.3 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.3 | 1.9 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.3 | 1.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.3 | 1.1 | GO:1902871 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
0.3 | 0.8 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.3 | 1.3 | GO:2000813 | negative regulation of barbed-end actin filament capping(GO:2000813) |
0.3 | 0.8 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
0.3 | 1.3 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.3 | 2.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.3 | 1.3 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.3 | 1.5 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
0.3 | 2.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.3 | 1.5 | GO:0043366 | beta selection(GO:0043366) |
0.2 | 1.2 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.2 | 1.0 | GO:0002215 | defense response to nematode(GO:0002215) |
0.2 | 0.7 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
0.2 | 1.2 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.2 | 1.7 | GO:0006154 | adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
0.2 | 7.7 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.2 | 0.9 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
0.2 | 2.1 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.2 | 2.5 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 0.5 | GO:0071623 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
0.2 | 0.7 | GO:2000656 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
0.2 | 0.7 | GO:0046108 | uridine metabolic process(GO:0046108) |
0.2 | 0.7 | GO:0038158 | granulocyte colony-stimulating factor signaling pathway(GO:0038158) |
0.2 | 1.3 | GO:2001107 | negative regulation of establishment of T cell polarity(GO:1903904) negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
0.2 | 0.7 | GO:0097536 | peripheral T cell tolerance induction(GO:0002458) peripheral tolerance induction(GO:0002465) thymus epithelium morphogenesis(GO:0097536) regulation of thymocyte migration(GO:2000410) |
0.2 | 0.6 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.2 | 0.2 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.2 | 0.6 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.2 | 0.4 | GO:0002339 | B cell selection(GO:0002339) |
0.2 | 0.6 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 0.6 | GO:0098583 | mastication(GO:0071626) learned vocalization behavior(GO:0098583) |
0.2 | 1.0 | GO:0002924 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.2 | 0.8 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.2 | 3.3 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.2 | 1.0 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.2 | 0.4 | GO:0032499 | detection of peptidoglycan(GO:0032499) |
0.2 | 1.2 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.2 | 3.1 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.2 | 0.6 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 0.6 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
0.2 | 0.6 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.2 | 2.1 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
0.2 | 2.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 1.7 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.2 | 4.5 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 1.5 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.2 | 1.5 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
0.2 | 1.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.2 | 1.3 | GO:0070269 | pyroptosis(GO:0070269) |
0.2 | 0.9 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) interleukin-5-mediated signaling pathway(GO:0038043) interleukin-3-mediated signaling pathway(GO:0038156) |
0.2 | 0.5 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.2 | 3.1 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.2 | 0.9 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
0.2 | 0.5 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
0.2 | 0.5 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
0.2 | 1.1 | GO:1903412 | response to bile acid(GO:1903412) |
0.2 | 1.6 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.2 | 1.8 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.2 | 1.1 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.2 | 1.2 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.2 | 38.0 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.2 | 1.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.2 | 0.9 | GO:1903974 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
0.2 | 1.7 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.2 | 1.2 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.2 | 0.9 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.2 | 0.5 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.2 | 0.7 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.2 | 4.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 1.2 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.2 | 1.0 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.2 | 0.5 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.2 | 3.2 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.2 | 1.0 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.2 | 2.1 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.2 | 0.6 | GO:0070295 | renal water absorption(GO:0070295) |
0.2 | 0.8 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
0.2 | 0.5 | GO:0014810 | positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014810) |
0.2 | 0.6 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.2 | 1.8 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.1 | 1.2 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.1 | 0.9 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.4 | GO:1902997 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) regulation of neurofibrillary tangle assembly(GO:1902996) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
0.1 | 0.7 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 0.4 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 2.9 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 1.6 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.7 | GO:2000538 | regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
0.1 | 0.4 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
0.1 | 0.1 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.1 | 0.1 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.1 | 0.4 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.1 | 0.6 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.1 | 0.6 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
0.1 | 0.6 | GO:1900148 | Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
0.1 | 1.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.4 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.1 | 1.3 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.1 | 0.6 | GO:0036367 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.1 | 0.4 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.1 | 1.8 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.1 | 3.0 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 0.4 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.1 | 0.5 | GO:0035498 | carnosine metabolic process(GO:0035498) |
0.1 | 0.1 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
0.1 | 1.6 | GO:0035878 | nail development(GO:0035878) |
0.1 | 1.1 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.1 | 0.3 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
0.1 | 1.8 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.1 | 0.7 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 2.7 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
0.1 | 0.8 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.1 | 2.1 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 1.0 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.1 | 0.6 | GO:0015855 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
0.1 | 1.2 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.5 | GO:0044407 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
0.1 | 0.4 | GO:0019483 | uracil catabolic process(GO:0006212) beta-alanine biosynthetic process(GO:0019483) |
0.1 | 2.0 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.4 | GO:0015917 | aminophospholipid transport(GO:0015917) regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
0.1 | 2.7 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.3 | GO:0042427 | serotonin biosynthetic process(GO:0042427) |
0.1 | 1.5 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.1 | 0.4 | GO:0036323 | vascular endothelial growth factor receptor-1 signaling pathway(GO:0036323) |
0.1 | 0.5 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.1 | 1.2 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 1.9 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 1.4 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.1 | 0.5 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.6 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.5 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.1 | 0.4 | GO:1990637 | response to prolactin(GO:1990637) |
0.1 | 0.2 | GO:0043307 | eosinophil activation(GO:0043307) |
0.1 | 0.8 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.4 | GO:0051939 | gamma-aminobutyric acid import(GO:0051939) |
0.1 | 0.1 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
0.1 | 0.2 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
0.1 | 2.6 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.1 | 0.2 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.1 | 0.6 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
0.1 | 1.6 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 2.0 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.8 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 | 0.6 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.1 | 0.3 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.1 | 0.9 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.1 | 2.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 2.4 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 0.4 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 1.8 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 4.8 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 1.2 | GO:0032264 | IMP salvage(GO:0032264) |
0.1 | 0.4 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
0.1 | 0.8 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 2.6 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 0.3 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.1 | 0.4 | GO:0014060 | regulation of epinephrine secretion(GO:0014060) negative regulation of epinephrine secretion(GO:0032811) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) epinephrine secretion(GO:0048242) |
0.1 | 0.5 | GO:1902965 | membrane to membrane docking(GO:0022614) regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.1 | 1.2 | GO:0035766 | cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) |
0.1 | 1.5 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.1 | 0.6 | GO:0032571 | response to vitamin K(GO:0032571) |
0.1 | 0.8 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
0.1 | 3.3 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.1 | 0.3 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.1 | 0.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.6 | GO:1901569 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
0.1 | 0.3 | GO:0044725 | chromatin reprogramming in the zygote(GO:0044725) |
0.1 | 0.5 | GO:0003070 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.1 | 2.6 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.2 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.1 | 0.5 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.8 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 1.8 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.1 | 2.7 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 0.1 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.1 | 0.4 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
0.1 | 0.4 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.1 | 0.6 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.1 | 0.4 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.1 | 0.4 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
0.1 | 0.6 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.1 | 0.9 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.1 | 0.1 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.1 | 7.2 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.5 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.1 | 0.5 | GO:0060369 | positive regulation of natural killer cell cytokine production(GO:0002729) positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
0.1 | 0.3 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.1 | 0.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.3 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.1 | 0.4 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.1 | 0.4 | GO:1902904 | vacuolar transmembrane transport(GO:0034486) chaperone-mediated protein transport involved in chaperone-mediated autophagy(GO:0061741) negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
0.1 | 0.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 1.7 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.3 | GO:0006173 | dADP biosynthetic process(GO:0006173) |
0.1 | 0.2 | GO:0030862 | positive regulation of polarized epithelial cell differentiation(GO:0030862) |
0.1 | 0.2 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.1 | 0.3 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
0.1 | 0.2 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.4 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
0.1 | 0.6 | GO:0071964 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
0.1 | 0.6 | GO:0003363 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) |
0.1 | 1.5 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.2 | GO:0010266 | response to vitamin B1(GO:0010266) |
0.1 | 0.6 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.1 | 0.5 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.1 | 0.7 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 1.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.4 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 0.5 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.1 | 0.2 | GO:2000588 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
0.1 | 1.4 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 1.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.8 | GO:1902741 | interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
0.1 | 0.9 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.2 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.1 | 0.3 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.1 | 0.8 | GO:0002084 | protein depalmitoylation(GO:0002084) |
0.1 | 2.5 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 2.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.2 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.1 | 0.2 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.1 | 0.3 | GO:0014740 | negative regulation of muscle hyperplasia(GO:0014740) |
0.1 | 0.4 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.4 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.1 | 1.4 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.2 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.1 | 0.2 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.1 | 0.4 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.1 | 1.6 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 0.6 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.3 | GO:0034445 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
0.1 | 0.8 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.6 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.4 | GO:1902075 | cellular response to salt(GO:1902075) |
0.1 | 0.3 | GO:1902724 | positive regulation of skeletal muscle cell proliferation(GO:0014858) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
0.1 | 0.6 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.1 | 8.0 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 1.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 1.7 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.2 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.1 | 0.8 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 0.1 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.4 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 0.4 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.1 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.1 | 1.9 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.9 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 2.2 | GO:0030220 | platelet formation(GO:0030220) |
0.1 | 0.5 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 1.2 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.3 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 0.2 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
0.1 | 0.6 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.1 | 1.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.2 | GO:0014813 | skeletal muscle satellite cell commitment(GO:0014813) |
0.1 | 0.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.2 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.1 | 1.2 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.5 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 0.4 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.1 | 1.0 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.6 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.7 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.3 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.1 | 0.8 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.2 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.6 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 6.7 | GO:0031295 | T cell costimulation(GO:0031295) |
0.1 | 2.5 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.1 | 0.6 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 1.5 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.5 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.2 | GO:1904306 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) positive regulation of gastro-intestinal system smooth muscle contraction(GO:1904306) |
0.1 | 0.2 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.1 | 0.7 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.2 | GO:0061402 | cellular response to potassium ion starvation(GO:0051365) positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
0.1 | 0.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.6 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.3 | GO:1903961 | positive regulation of anion channel activity(GO:1901529) positive regulation of anion transmembrane transport(GO:1903961) |
0.1 | 0.9 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.9 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.2 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.1 | 0.5 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 1.5 | GO:0051412 | response to corticosterone(GO:0051412) |
0.1 | 0.2 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) amino sugar biosynthetic process(GO:0046349) |
0.1 | 1.2 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.6 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 1.0 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.2 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
0.1 | 0.2 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
0.1 | 0.4 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.1 | 2.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.5 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.3 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.1 | 0.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.2 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 0.2 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
0.1 | 0.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.2 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.1 | 2.5 | GO:0042100 | B cell proliferation(GO:0042100) |
0.1 | 1.0 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 2.2 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.1 | 0.4 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 1.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 3.6 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.3 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.1 | 0.6 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.1 | 0.1 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.1 | 0.2 | GO:0031106 | septin ring assembly(GO:0000921) septin ring organization(GO:0031106) regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
0.0 | 0.1 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
0.0 | 1.1 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.0 | 0.6 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.4 | GO:0071442 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.0 | 0.3 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.4 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.0 | 3.3 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.6 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.0 | 0.2 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.0 | 0.3 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 2.0 | GO:0035640 | exploration behavior(GO:0035640) |
0.0 | 0.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.0 | 0.7 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.0 | 0.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.3 | GO:0007172 | signal complex assembly(GO:0007172) |
0.0 | 0.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.0 | 1.2 | GO:0036508 | protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) endoplasmic reticulum mannose trimming(GO:1904380) |
0.0 | 0.5 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 4.1 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 3.2 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.7 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 2.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.5 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.0 | 0.9 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 0.3 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.0 | 0.4 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.0 | 0.2 | GO:1990910 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
0.0 | 0.6 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.0 | 1.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.4 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.0 | 0.7 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.2 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.0 | 0.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.0 | 1.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 3.1 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.0 | 0.3 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
0.0 | 1.7 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.0 | 0.0 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.0 | 1.5 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
0.0 | 1.5 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.0 | 0.4 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.0 | 0.2 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.0 | 0.2 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.0 | 0.2 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.0 | 0.2 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.0 | 0.2 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.0 | 1.2 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.3 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.5 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.0 | 28.8 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.0 | 2.8 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.1 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.0 | 0.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.4 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.0 | 0.2 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.0 | 0.8 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.0 | 0.1 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.0 | 0.2 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.0 | 0.2 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.0 | 0.3 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.0 | 0.3 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 0.7 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 1.1 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.0 | 0.2 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.0 | 0.4 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.0 | 0.6 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 1.3 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.5 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.0 | 0.2 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.0 | 0.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.1 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.4 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.3 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.0 | 0.4 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.0 | 0.4 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.1 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 3.7 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.0 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.3 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
0.0 | 0.2 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.0 | 0.3 | GO:0050862 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.0 | 0.5 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.0 | 0.5 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.0 | 0.2 | GO:0042560 | folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
0.0 | 0.4 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.1 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
0.0 | 0.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.0 | 0.5 | GO:0002385 | mucosal immune response(GO:0002385) |
0.0 | 0.8 | GO:0097421 | liver regeneration(GO:0097421) |
0.0 | 0.5 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.7 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.4 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.0 | 0.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.0 | 0.4 | GO:0036371 | protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
0.0 | 3.8 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 0.1 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.0 | 0.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.0 | 0.4 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.0 | 0.2 | GO:0045914 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.0 | 1.3 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.1 | GO:0090410 | malonate catabolic process(GO:0090410) |
0.0 | 1.4 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
0.0 | 1.0 | GO:0021762 | substantia nigra development(GO:0021762) |
0.0 | 0.2 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.0 | 0.4 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 | 0.9 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.1 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.7 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 0.1 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.0 | 1.0 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.0 | 3.6 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 0.2 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.0 | 0.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.0 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.0 | 1.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 2.6 | GO:0007041 | lysosomal transport(GO:0007041) |
0.0 | 0.9 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.0 | 0.3 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.0 | 0.2 | GO:0006696 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.0 | 0.6 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.1 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.0 | 0.5 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.0 | 0.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.0 | 0.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.2 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.0 | 0.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.4 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.2 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.0 | 0.8 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.0 | 0.2 | GO:0034311 | diol metabolic process(GO:0034311) |
0.0 | 0.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.3 | GO:0070560 | protein secretion by platelet(GO:0070560) |
0.0 | 4.3 | GO:0045047 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.0 | 0.5 | GO:0003322 | pancreatic A cell development(GO:0003322) |
0.0 | 0.1 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.0 | 0.9 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.3 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.3 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.0 | 0.1 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
0.0 | 0.2 | GO:0001712 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
0.0 | 0.8 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 1.5 | GO:0046849 | bone remodeling(GO:0046849) |
0.0 | 0.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.0 | 0.1 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
0.0 | 0.3 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.0 | 0.6 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 0.2 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 1.3 | GO:1902041 | regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902041) |
0.0 | 0.3 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.1 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.0 | 0.3 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 2.1 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.0 | 2.0 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.5 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.7 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.0 | 0.8 | GO:0038093 | Fc receptor signaling pathway(GO:0038093) |
0.0 | 0.2 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.0 | 0.8 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.0 | 0.4 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.2 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.0 | 0.3 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 0.2 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.0 | 1.1 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.0 | 0.5 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.0 | 0.6 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.5 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.0 | 0.4 | GO:0010226 | response to lithium ion(GO:0010226) |
0.0 | 0.1 | GO:0019413 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate biosynthetic process(GO:0019542) |
0.0 | 0.1 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
0.0 | 0.2 | GO:0009414 | response to water deprivation(GO:0009414) |
0.0 | 0.1 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) axo-dendritic protein transport(GO:0099640) |
0.0 | 0.2 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.0 | 0.2 | GO:0021592 | fourth ventricle development(GO:0021592) |
0.0 | 2.2 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
0.0 | 0.2 | GO:0042730 | fibrinolysis(GO:0042730) |
0.0 | 0.8 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.2 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 2.0 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
0.0 | 0.1 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.0 | 0.7 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.0 | 0.5 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 0.7 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.0 | 0.1 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.0 | 0.1 | GO:0034340 | response to type I interferon(GO:0034340) |
0.0 | 0.3 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 0.1 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.0 | 1.1 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 1.7 | GO:0015992 | proton transport(GO:0015992) |
0.0 | 0.1 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.0 | 0.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.0 | 0.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.0 | 0.4 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.0 | 0.2 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 0.0 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.0 | 0.2 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.0 | 0.1 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.0 | 0.1 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.0 | 0.1 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.3 | GO:2000394 | regulation of GTP binding(GO:1904424) positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.0 | 0.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.3 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.0 | 0.3 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.1 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.0 | 0.2 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.0 | 0.6 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
0.0 | 0.1 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.3 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) |
0.0 | 0.3 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.2 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.1 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.0 | 0.2 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.0 | 0.1 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 2.1 | GO:0002250 | adaptive immune response(GO:0002250) |
0.0 | 0.0 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.0 | 1.5 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.0 | 0.5 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.0 | 0.4 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.0 | 0.1 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.0 | 0.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.0 | 4.4 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.2 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.0 | 0.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.1 | GO:2000322 | regulation of glucocorticoid receptor signaling pathway(GO:2000322) positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.0 | 0.4 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.4 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.0 | 0.2 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 0.0 | GO:0046035 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.0 | 0.0 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.0 | 0.3 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.2 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.0 | 0.5 | GO:0019985 | translesion synthesis(GO:0019985) |
0.0 | 0.5 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.0 | 0.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.0 | 0.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 8.0 | GO:0071749 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
1.0 | 6.7 | GO:1990031 | pinceau fiber(GO:1990031) |
0.8 | 4.2 | GO:1990742 | microvesicle(GO:1990742) |
0.8 | 41.8 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.7 | 3.6 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.5 | 2.7 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.5 | 1.9 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.4 | 3.2 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.4 | 1.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.4 | 11.1 | GO:0042599 | lamellar body(GO:0042599) |
0.3 | 1.0 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
0.3 | 1.0 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.3 | 2.8 | GO:0044194 | cytolytic granule(GO:0044194) |
0.3 | 0.3 | GO:0044301 | climbing fiber(GO:0044301) |
0.3 | 0.9 | GO:0030526 | granulocyte macrophage colony-stimulating factor receptor complex(GO:0030526) |
0.3 | 1.8 | GO:0097441 | basilar dendrite(GO:0097441) |
0.3 | 1.7 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.3 | 1.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.3 | 3.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.2 | 4.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 4.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 0.4 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.2 | 0.9 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
0.2 | 1.8 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 2.6 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.2 | 1.3 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 0.6 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.2 | 2.1 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
0.2 | 7.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 0.8 | GO:0070701 | mucus layer(GO:0070701) |
0.2 | 6.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 2.2 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.2 | 2.0 | GO:0032010 | phagolysosome(GO:0032010) |
0.2 | 0.6 | GO:0036284 | tubulobulbar complex(GO:0036284) |
0.2 | 0.7 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 0.9 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.2 | 0.5 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.2 | 0.5 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.2 | 1.8 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.2 | 3.2 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 0.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.4 | GO:0099569 | cytoskeleton of presynaptic active zone(GO:0048788) presynaptic active zone cytoplasmic component(GO:0098831) presynaptic cytoskeleton(GO:0099569) |
0.1 | 0.3 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.1 | 0.5 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 1.1 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 1.2 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.1 | 2.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 9.7 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.1 | 13.5 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.1 | 3.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 23.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.3 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
0.1 | 1.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.7 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 0.9 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.1 | 0.9 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.7 | GO:0097386 | glial cell projection(GO:0097386) |
0.1 | 0.6 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 1.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 8.1 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 0.6 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.1 | 4.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 0.6 | GO:0044753 | amphisome(GO:0044753) |
0.1 | 0.6 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 1.0 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.1 | 2.3 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.8 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.1 | 3.8 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.1 | 0.3 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
0.1 | 0.8 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 0.4 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.1 | 4.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.2 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 6.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 2.9 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.2 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
0.1 | 0.6 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 3.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.2 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.1 | 0.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 1.3 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.2 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.1 | 0.5 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 0.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 3.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.4 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 0.3 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.1 | 4.7 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.1 | 0.5 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.1 | 1.1 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 1.6 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 1.4 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.5 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 0.2 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.1 | 0.9 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 1.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.3 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.1 | 0.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 4.9 | GO:0035580 | specific granule lumen(GO:0035580) |
0.1 | 0.6 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 0.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 12.5 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 3.6 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.6 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 1.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 1.5 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 1.8 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 0.3 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.0 | 1.5 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 2.9 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.5 | GO:0061702 | inflammasome complex(GO:0061702) |
0.0 | 0.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.0 | 1.5 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.0 | 0.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 0.2 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.0 | 9.3 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 0.6 | GO:0097433 | dense body(GO:0097433) |
0.0 | 0.3 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.0 | 0.7 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 4.6 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 0.3 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.5 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.4 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.2 | GO:0000811 | GINS complex(GO:0000811) |
0.0 | 1.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 0.6 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 0.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.2 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
0.0 | 0.5 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.1 | GO:0097443 | sorting endosome(GO:0097443) |
0.0 | 0.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.0 | 0.7 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.5 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.0 | 0.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.6 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.2 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.4 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 1.4 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 1.2 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.3 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 0.3 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 9.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.6 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.3 | GO:0060171 | stereocilium membrane(GO:0060171) |
0.0 | 4.1 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 0.9 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.0 | 2.3 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.0 | 0.4 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.7 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 1.3 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 0.2 | GO:0016013 | syntrophin complex(GO:0016013) |
0.0 | 0.2 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.0 | 3.3 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.0 | 0.8 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 0.1 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.0 | 0.2 | GO:0070876 | SOSS complex(GO:0070876) |
0.0 | 5.2 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 4.3 | GO:0030133 | transport vesicle(GO:0030133) |
0.0 | 0.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.6 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.0 | 0.3 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 1.6 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 40.0 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 1.0 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.2 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.0 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.0 | GO:0060187 | cell pole(GO:0060187) |
0.0 | 0.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.0 | 0.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.4 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.4 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
0.0 | 0.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.2 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
0.0 | 0.1 | GO:0002133 | polycystin complex(GO:0002133) |
0.0 | 0.0 | GO:0031251 | PAN complex(GO:0031251) |
0.0 | 32.5 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.0 | 0.2 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.9 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.1 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.0 | 1.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 1.3 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.5 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 1.1 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.0 | 0.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.2 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.0 | 0.0 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.0 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 0.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.0 | 0.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.8 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.1 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.1 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 1.4 | GO:0034774 | secretory granule lumen(GO:0034774) |
0.0 | 0.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.0 | GO:0032116 | SMC loading complex(GO:0032116) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.1 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
0.7 | 50.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.7 | 4.0 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.7 | 12.0 | GO:0019864 | IgG binding(GO:0019864) |
0.6 | 2.6 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.6 | 1.9 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.6 | 2.4 | GO:0032408 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
0.6 | 1.7 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.5 | 1.6 | GO:0036505 | prosaposin receptor activity(GO:0036505) |
0.5 | 2.5 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.4 | 1.3 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
0.4 | 1.3 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
0.4 | 1.7 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
0.4 | 1.2 | GO:0035375 | zymogen binding(GO:0035375) |
0.4 | 87.8 | GO:0003823 | antigen binding(GO:0003823) |
0.4 | 5.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.4 | 1.6 | GO:0033897 | ribonuclease T2 activity(GO:0033897) |
0.4 | 1.9 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
0.4 | 1.1 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.4 | 2.5 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.4 | 2.1 | GO:0039552 | RIG-I binding(GO:0039552) |
0.3 | 1.0 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.3 | 1.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.3 | 1.0 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.3 | 1.3 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.3 | 0.9 | GO:0004056 | argininosuccinate lyase activity(GO:0004056) |
0.3 | 1.5 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.3 | 0.3 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.3 | 2.5 | GO:0019863 | IgE binding(GO:0019863) |
0.3 | 1.9 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.3 | 0.8 | GO:0032093 | SAM domain binding(GO:0032093) |
0.3 | 5.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 2.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.2 | 0.7 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
0.2 | 1.2 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.2 | 0.7 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.2 | 2.3 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.2 | 3.3 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.2 | 1.1 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.2 | 0.7 | GO:0019785 | ISG15-specific protease activity(GO:0019785) |
0.2 | 0.6 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.2 | 0.6 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.2 | 0.8 | GO:0002046 | opsin binding(GO:0002046) |
0.2 | 1.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 0.6 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 3.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 1.0 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.2 | 1.4 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.2 | 2.1 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.2 | 3.2 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.2 | 1.2 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.2 | 0.6 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.2 | 0.8 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.2 | 0.4 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.2 | 1.2 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.2 | 1.0 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.2 | 0.8 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.2 | 3.7 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 2.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 0.4 | GO:0090556 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.2 | 1.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 0.6 | GO:0017129 | triglyceride binding(GO:0017129) |
0.2 | 0.9 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) interleukin-5 receptor activity(GO:0004914) |
0.2 | 1.6 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.2 | 0.7 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.2 | 1.6 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.2 | 0.9 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.2 | 1.2 | GO:0042806 | fucose binding(GO:0042806) |
0.2 | 0.7 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
0.2 | 1.7 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.2 | 0.7 | GO:0016880 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 1.4 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.2 | 1.7 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.2 | 2.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.2 | 1.0 | GO:0050436 | microfibril binding(GO:0050436) |
0.2 | 0.6 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.2 | 0.2 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.2 | 2.6 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.4 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
0.1 | 2.1 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 3.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 1.3 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 0.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 2.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.4 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
0.1 | 1.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 3.1 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 1.2 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.1 | 2.2 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 0.5 | GO:0004733 | pyridoxamine-phosphate oxidase activity(GO:0004733) |
0.1 | 0.5 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.1 | 0.8 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 0.5 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 5.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 1.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.4 | GO:0036326 | VEGF-A-activated receptor activity(GO:0036326) VEGF-B-activated receptor activity(GO:0036327) placental growth factor-activated receptor activity(GO:0036332) |
0.1 | 1.6 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.4 | GO:0008988 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) |
0.1 | 1.3 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.1 | 0.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.6 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.4 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
0.1 | 1.2 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.7 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.1 | 0.5 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 1.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 4.8 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 1.2 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.1 | 4.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.9 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.5 | GO:0052839 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
0.1 | 0.5 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.4 | GO:1904492 | Ac-Asp-Glu binding(GO:1904492) tetrahydrofolyl-poly(glutamate) polymer binding(GO:1904493) |
0.1 | 0.4 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.1 | 0.5 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
0.1 | 0.5 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 0.5 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.9 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 1.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 2.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.4 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.1 | 1.9 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.6 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.1 | 4.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.9 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 0.9 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.3 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
0.1 | 0.5 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 2.8 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.6 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.6 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 0.4 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
0.1 | 1.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 6.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.1 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
0.1 | 0.3 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 0.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 3.2 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 0.5 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.1 | 1.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.3 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.1 | 1.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 1.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.3 | GO:1902271 | D3 vitamins binding(GO:1902271) |
0.1 | 0.2 | GO:1904854 | proteasome core complex binding(GO:1904854) |
0.1 | 2.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 1.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.6 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 4.3 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.8 | GO:0042835 | BRE binding(GO:0042835) |
0.1 | 0.4 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.1 | 0.2 | GO:0086059 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) voltage-gated calcium channel activity involved SA node cell action potential(GO:0086059) |
0.1 | 0.9 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.3 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.1 | 0.2 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.1 | 0.8 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.4 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.3 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) ethanolaminephosphotransferase activity(GO:0004307) |
0.1 | 0.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 2.3 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.3 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 0.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 1.7 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.5 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.7 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 1.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 2.0 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.6 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.3 | GO:0008478 | pyridoxal kinase activity(GO:0008478) |
0.1 | 0.5 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.1 | 0.1 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.1 | 0.3 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
0.1 | 2.6 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 1.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.3 | GO:0016890 | site-specific endodeoxyribonuclease activity, specific for altered base(GO:0016890) |
0.1 | 0.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.8 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 4.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 2.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.3 | GO:0004773 | steryl-sulfatase activity(GO:0004773) |
0.1 | 1.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 1.5 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.1 | 2.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.5 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.1 | 2.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.4 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 1.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.8 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.8 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.2 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.2 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.1 | 2.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.3 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.1 | 0.2 | GO:0031208 | POZ domain binding(GO:0031208) |
0.1 | 0.2 | GO:0047860 | diiodophenylpyruvate reductase activity(GO:0047860) |
0.1 | 0.2 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.1 | 0.4 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.1 | 2.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.3 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 5.0 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.5 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.3 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 0.4 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.2 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 0.5 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 1.5 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 1.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.3 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.1 | 0.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.5 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 2.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.5 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.3 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
0.0 | 1.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.5 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 0.4 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.0 | 0.3 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.0 | 0.5 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.3 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.0 | 0.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.4 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.0 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.6 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 1.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.4 | GO:0052796 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.3 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.3 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.0 | 1.4 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 2.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 1.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 21.6 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.3 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.0 | 0.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.2 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.0 | 0.8 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.0 | 0.2 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.0 | 0.2 | GO:0052901 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
0.0 | 0.4 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.7 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.3 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
0.0 | 0.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 1.3 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.0 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.0 | 0.5 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 3.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.2 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.0 | 2.8 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 1.6 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.6 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 1.0 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.4 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.0 | 2.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.1 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
0.0 | 0.4 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
0.0 | 0.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.2 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.0 | 1.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.0 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.0 | 1.3 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.4 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.0 | 0.4 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.2 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.0 | 2.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 1.1 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.0 | 0.6 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.9 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.3 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.7 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 1.1 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.4 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.8 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.3 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.0 | 0.3 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.0 | 0.1 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.0 | 0.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.8 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 2.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.1 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.0 | 0.2 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.0 | 0.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 1.4 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.0 | 0.1 | GO:0061598 | nitrate reductase activity(GO:0008940) molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
0.0 | 0.1 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
0.0 | 0.2 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.0 | 0.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 1.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 2.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.4 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.4 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.2 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.0 | 0.1 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
0.0 | 0.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.6 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 15.9 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.3 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.0 | 2.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.3 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.0 | 1.3 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.4 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.0 | 0.2 | GO:1902444 | riboflavin binding(GO:1902444) |
0.0 | 0.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.3 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.0 | 1.1 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.0 | 0.4 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.1 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.7 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.3 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.0 | 0.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.4 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.0 | 0.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.2 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.1 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.4 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.4 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.1 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.0 | 0.2 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.0 | 0.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.8 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.2 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.2 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.1 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 7.5 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 3.1 | GO:0005496 | steroid binding(GO:0005496) |
0.0 | 0.2 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.0 | 0.2 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 2.6 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.9 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.1 | GO:0004001 | adenosine kinase activity(GO:0004001) |
0.0 | 0.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.3 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.0 | 0.1 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.0 | 0.1 | GO:0045485 | omega-6 fatty acid desaturase activity(GO:0045485) |
0.0 | 0.3 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.0 | 0.1 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.0 | 0.4 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
0.0 | 0.1 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.0 | 0.1 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.0 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 2.6 | GO:0002020 | protease binding(GO:0002020) |
0.0 | 0.1 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 1.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.1 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.0 | 0.3 | GO:0016918 | retinal binding(GO:0016918) |
0.0 | 0.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.2 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.2 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.1 | GO:0008732 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.0 | 0.1 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.0 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 5.3 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 0.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.0 | 0.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 4.4 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.1 | GO:1901612 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
0.0 | 0.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.0 | 0.1 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.0 | 0.0 | GO:0051425 | PTB domain binding(GO:0051425) |
0.0 | 0.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.2 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.0 | 0.7 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.8 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.1 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.4 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 0.1 | GO:0005124 | scavenger receptor binding(GO:0005124) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.9 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 16.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 5.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 8.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 0.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 14.3 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 6.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.7 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 3.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 7.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 3.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 2.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 5.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 3.8 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 6.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 7.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 0.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 7.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 1.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 3.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 3.5 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 0.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 1.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 20.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 2.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 2.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 2.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 1.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 2.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 1.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 1.8 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 1.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 1.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 5.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 1.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.8 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 1.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.8 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 1.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 1.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 2.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 2.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 3.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.9 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.7 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 9.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 1.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 1.1 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.4 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.1 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.7 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 3.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 1.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.7 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.7 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 1.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 1.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 1.2 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 1.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.4 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 1.5 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 10.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 6.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 3.7 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 1.9 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 2.7 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 1.7 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.2 | 3.7 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 2.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 15.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 2.9 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 2.4 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.4 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 0.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 8.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 2.3 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 7.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 3.0 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 1.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 1.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 5.3 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 6.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 3.4 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 3.3 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 4.0 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.1 | 3.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.6 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 2.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 2.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 1.2 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.1 | 0.4 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 2.4 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 3.6 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 1.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 6.4 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 2.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 1.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 2.0 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 0.9 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 1.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.1 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 1.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 1.1 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.1 | 0.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 6.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 5.6 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 3.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.7 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 2.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 1.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 1.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.7 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 1.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 1.6 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 1.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 2.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.9 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.8 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.6 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.8 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.1 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.0 | 0.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 1.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 1.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 3.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 1.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 1.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.1 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.0 | 0.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 6.8 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 1.0 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.5 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.0 | 0.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 1.5 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.9 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.6 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.6 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.4 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 1.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 1.4 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.0 | 1.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.6 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.5 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.4 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 1.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 2.8 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 1.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.5 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.0 | 0.5 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 1.1 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.5 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 1.0 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.7 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.8 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.5 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |